Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, May 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Shareholders say they're not getting enough from defendant Schering-Plough's $41.1 billion sale to Merck, in Newark Federal Court.

Bondholders say GMAC's restructuring plan will unfairly subordinate their bonds to the new ones, in Delaware Federal Court. Also sued is Cerberus Capital Management.

Anesiva's board made it difficult or impossible to be acquired without unfairly benefitting the directors, according to a derivative complaint in Delaware Chancery Court. Anesiva is a biopharmaceutical company. Here are the defendants: Daniel Janney; Arnold Oronsky; Michael Powell; Rodney Ferguson; Michael Kranda; Alta Partners VIII LP; Alta California Partners III LP; Alta Embarcadero Partners III LLC; Interwest Partners VIII LP; Interwest Investors Q VIII LP; Interwest Investors VIII LP; Sofinnova Venture Partners V LP; Sofinnova Venture Affiliates V LP; Sofinnova Venture Principals V LP; Sofinnova Venture Partners VII LP; CMEA Ventures VII LP; CMEA Ventures VII (Parallel) LP; Anesiva Inc.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...